311 related articles for article (PubMed ID: 29575491)
1. Optimization of reprogramming culture conditions for the generation of induced pluripotent stem cells from Col1a1 4F2A-Oct4-GFP mice with high efficiency.
Lin PY; Hsu SC; Chen HC; Len WB; Hsiao FC; Liu MC; Pan PL; Lin TC; Lee YH; Meir YJ
FEBS J; 2018 May; 285(9):1667-1683. PubMed ID: 29575491
[TBL] [Abstract][Full Text] [Related]
2. Continuous expression of reprogramming factors induces and maintains mouse pluripotency without specific growth factors and signaling inhibitors.
Mao Y; Wang L; Zhong B; Yang N; Li Z; Cui T; Feng G; Li W; Zhang Y; Zhou Q
Cell Prolif; 2021 Aug; 54(8):e13090. PubMed ID: 34197016
[TBL] [Abstract][Full Text] [Related]
3. Using Oct4:MerCreMer Lineage Tracing to Monitor Endogenous Oct4 Expression During the Reprogramming of Fibroblasts into Induced Pluripotent Stem Cells (iPSCs).
Greder LV; Post J; Dutton JR
Methods Mol Biol; 2016; 1357():97-110. PubMed ID: 25687297
[TBL] [Abstract][Full Text] [Related]
4. Regulation of c-Myc Expression by Ahnak Promotes Induced Pluripotent Stem Cell Generation.
Lim HJ; Kim J; Park CH; Lee SA; Lee MR; Kim KS; Kim J; Bae YS
J Biol Chem; 2016 Jan; 291(2):752-61. PubMed ID: 26598518
[TBL] [Abstract][Full Text] [Related]
5. A real-time pluripotency reporter for the long-term and real-time monitoring of pluripotency changes in induced pluripotent stem cells.
Shen HF; Li YL; Huang SH; Xia JW; Yao ZF; Xiao GF; Zhou Y; Li YC; Shi JW; Lin XL; Zhao WT; Sun Y; Tian YG; Jia JS; Xiao D
Aging (Albany NY); 2022 May; 14(10):4445-4458. PubMed ID: 35575836
[TBL] [Abstract][Full Text] [Related]
6. The efficiency of cell fusion-based reprogramming is affected by the somatic cell type and the in vitro age of somatic cells.
Tat PA; Sumer H; Pralong D; Verma PJ
Cell Reprogram; 2011 Aug; 13(4):331-44. PubMed ID: 21728816
[TBL] [Abstract][Full Text] [Related]
7. Reprogramming of human fibroblasts to induced pluripotent stem cells under xeno-free conditions.
Rodríguez-Pizà I; Richaud-Patin Y; Vassena R; González F; Barrero MJ; Veiga A; Raya A; Izpisúa Belmonte JC
Stem Cells; 2010 Jan; 28(1):36-44. PubMed ID: 19890879
[TBL] [Abstract][Full Text] [Related]
8. Differentiation efficiency of induced pluripotent stem cells depends on the number of reprogramming factors.
Löhle M; Hermann A; Glass H; Kempe A; Schwarz SC; Kim JB; Poulet C; Ravens U; Schwarz J; Schöler HR; Storch A
Stem Cells; 2012 Mar; 30(3):570-9. PubMed ID: 22213586
[TBL] [Abstract][Full Text] [Related]
9. Derivation of human induced pluripotent stem cells through continued exposure of OCT4-induced plastic human fibroblasts to reprogramming media.
Salci KR; Lee JB; Mitchell RR; Orlando L; Fiebig-Comyn A; Shapovalova Z; Bhatia M
Stem Cell Res; 2015 Jul; 15(1):240-2. PubMed ID: 26141785
[TBL] [Abstract][Full Text] [Related]
10. Genetic background affects induced pluripotent stem cell generation.
Schnabel LV; Abratte CM; Schimenti JC; Southard TL; Fortier LA
Stem Cell Res Ther; 2012 Aug; 3(4):30. PubMed ID: 22862934
[TBL] [Abstract][Full Text] [Related]
11. The oncogene c-Jun impedes somatic cell reprogramming.
Liu J; Han Q; Peng T; Peng M; Wei B; Li D; Wang X; Yu S; Yang J; Cao S; Huang K; Hutchins AP; Liu H; Kuang J; Zhou Z; Chen J; Wu H; Guo L; Chen Y; Chen Y; Li X; Wu H; Liao B; He W; Song H; Yao H; Pan G; Chen J; Pei D
Nat Cell Biol; 2015 Jul; 17(7):856-67. PubMed ID: 26098572
[TBL] [Abstract][Full Text] [Related]
12. Rapid generation of secondary fibroblasts through teratoma formation.
Cho SM; Park JS; Min B; Kwon S; Kang YK
Biotechniques; 2015 Jul; 59(1):34-41. PubMed ID: 26156782
[TBL] [Abstract][Full Text] [Related]
13. Small RNA-mediated regulation of iPS cell generation.
Li Z; Yang CS; Nakashima K; Rana TM
EMBO J; 2011 Mar; 30(5):823-34. PubMed ID: 21285944
[TBL] [Abstract][Full Text] [Related]
14. Brief report: combined chemical treatment enables Oct4-induced reprogramming from mouse embryonic fibroblasts.
Yuan X; Wan H; Zhao X; Zhu S; Zhou Q; Ding S
Stem Cells; 2011 Mar; 29(3):549-53. PubMed ID: 21425417
[TBL] [Abstract][Full Text] [Related]
15. Enhanced human somatic cell reprogramming efficiency by fusion of the MYC transactivation domain and OCT4.
Wang L; Huang D; Huang C; Yin Y; Vali K; Zhang M; Tang Y
Stem Cell Res; 2017 Dec; 25():88-97. PubMed ID: 29125994
[TBL] [Abstract][Full Text] [Related]
16. Improved generation of patient-specific induced pluripotent stem cells using a chemically-defined and matrigel-based approach.
Groß B; Sgodda M; Rasche M; Schambach A; Göhring G; Schlegelberger B; Greber B; Linden T; Reinhardt D; Cantz T; Klusmann JH
Curr Mol Med; 2013 Jun; 13(5):765-76. PubMed ID: 23642058
[TBL] [Abstract][Full Text] [Related]
17. Reactivation of Endogenous Genes and Epigenetic Remodeling Are Barriers for Generating Transgene-Free Induced Pluripotent Stem Cells in Pig.
Choi KH; Park JK; Son D; Hwang JY; Lee DK; Ka H; Park J; Lee CK
PLoS One; 2016; 11(6):e0158046. PubMed ID: 27336671
[TBL] [Abstract][Full Text] [Related]
18. The efficient generation of induced pluripotent stem (iPS) cells from adult mouse adipose tissue-derived and neural stem cells.
Tat PA; Sumer H; Jones KL; Upton K; Verma PJ
Cell Transplant; 2010; 19(5):525-36. PubMed ID: 20144262
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of transforming growth factor β (TGF-β) signaling can substitute for Oct4 protein in reprogramming and maintain pluripotency.
Tan F; Qian C; Tang K; Abd-Allah SM; Jing N
J Biol Chem; 2015 Feb; 290(7):4500-11. PubMed ID: 25548277
[TBL] [Abstract][Full Text] [Related]
20. Differences in the gene expression profiles of slow- and fast-forming preinduced pluripotent stem cell colonies.
Kwon S; Park JS; Min B; Kang YK
Stem Cells Int; 2015; 2015():195928. PubMed ID: 25945097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]